Ask AI
PIKALO1
PIKALO-1: Phase I/II Trial of PI3Kα Inhibitor LY4064809 for HR+, HER2-Negative PIK3CA-Mutant Advanced Breast Cancer

Released: December 22, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 22, 2025